Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer

NCT02483767 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

98

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: goserelin
DRUG: standard chemotherapy

Sponsor

Peking Union Medical College Hospital